Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 437 of 1,261

  1. US 10584389

    Cancer screening by detection of ultrastructural and molecular markers

    Northwestern University · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  2. US 10584356

    Multigenome retroviral vector preparations and methods and systems for producing and using same

    IMMUNE DESIGN CORP. · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  3. US 10584313

    Method of producing a differentiated mammalian cell comprising culturing a single mammalian blastomere

    Astellas Institute for Regenerative Medicine · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  4. US 10584337

    Modulatory polynucleotides

    VOYAGER THERAPEUTICS, INC. · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  5. US 10584306

    Surfactant microemulsions

    The Board of Regents of the University of Oklahoma · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  6. US 10584173

    Nucleic acids encoding high affinity antibodies to human IL-6 receptor

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  7. US 10584161

    Monoclonal antibodies specific for heartland virus and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  8. US 10584132

    SHMT inhibitors

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  9. US 10584147

    Procoagulant fusion compound

    BIOVERATIV THERAPEUTICS INC. · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  10. US 10584135

    Substituted 3,6-diazabicyclo[3.2.0]heptanes

    Indivior UK Limited · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  11. US 10584105

    Immunoproteasome inhibitor analogs

    The Regents of the University of California · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  12. US 10583199

    Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs

    Northwestern University · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  13. US 10583202

    Homologous recombination in multipotent adult progenitor cells

    Regents of the University of Minnesota · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  14. US 10584103

    Small molecule agonists of neurotensin receptor 1

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  15. US 10584097

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  16. US 10583148

    Methods and devices for bone infection treatment selection

    The United States Government · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  17. US 10583180

    Method for treating adenosine deaminase severe combined imunodeficiency

    The Regents of the University of California · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  18. US 10583173

    Methods of treating or preventing pruritis by blocking natriuretic polypeptide b

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  19. US 10583144

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  20. US 10583159

    Method for increasing performance of offspring

    UNITED ANIMAL HEALTH, INC. · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  21. US 10583088

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  22. US 10583126

    Compositions and methods of treating cardiac fibrosis with ifetroban

    Cumberland Pharmaceuticals Inc. · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  23. US 10583111

    Method for preventing or treating diseases associated with the inhibition of EGFR

    ONQUALITY PHARMACEUTICALS CHINA LTD. · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  24. US 10576073

    Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

    Theravance Biopharma R&D IP, LLC · Granted Mar 3, 2020 · Expires Feb 27, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.